Noninvasive evaluation of coronary endothelial function following sirolimus-eluting stent implantation by using positron emission tomography

Cardiology. 2009;114(3):157-63. doi: 10.1159/000226093. Epub 2009 Jun 24.

Abstract

Objective: Several invasive studies have reported delayed reendothelialization and endothelial dysfunction following sirolimus-eluting stent (SES) implantation. We evaluated the changes in coronary endothelial function following SES implantation by using a noninvasive method that involved positron emission tomography and cold pressor testing (CPT).

Methods: The study was conducted on 14 lesions on which percutaneous coronary intervention (PCI) was successively performed. The lesions were classified into 2 groups depending on the PCI performed: the conventional PCI group, in which 7 conventional PCIs (plain old balloon angioplasty or bare-metal stents) were performed, and the SES group, in which 7 SESs were implanted. Coronary endothelial function was defined as the percent increase in the myocardial blood flow (MBF) during CPT.

Results: The resting MBF in the segments distal to the PCI sites did not differ between the conventional PCI and SES groups; however, the MBF significantly decreased in the SES group during CPT.

Conclusions: These data suggest that SES implantation induces coronary endothelial dysfunction in the segments distal to the PCI sites.

Publication types

  • Clinical Trial

MeSH terms

  • Aged
  • Aged, 80 and over
  • Angioplasty, Balloon, Coronary*
  • Antibiotics, Antineoplastic / administration & dosage
  • Blood Vessel Prosthesis Implantation*
  • Cold Temperature
  • Coronary Artery Disease / diagnostic imaging
  • Coronary Artery Disease / physiopathology
  • Coronary Artery Disease / surgery*
  • Coronary Circulation
  • Coronary Vessels / diagnostic imaging*
  • Coronary Vessels / physiopathology
  • Drug-Eluting Stents
  • Endothelium, Vascular / diagnostic imaging*
  • Endothelium, Vascular / physiopathology
  • Female
  • Hemodynamics
  • Humans
  • Male
  • Middle Aged
  • Positron-Emission Tomography
  • Sirolimus / administration & dosage
  • Treatment Outcome

Substances

  • Antibiotics, Antineoplastic
  • Sirolimus